Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Kezar Life Sciences logo — Pioneering first-in-class, small-molecule therapies for immu...

Kezar Life Sciences

Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders

Founded 2015 United States South San Francisco, United States 71 employees Post Ipo Equity Total: $135.16M Health Care, Health and Wellness +1

General Information

Company Name Kezar Life Sciences
Founded Year 2015
Location United States South San Francisco, United States +1
Employees 71
Industries Health Care, Health and Wellness, Life Sciences
Funding Stage Post Ipo Equity
Social

Get notified when Kezar Life Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kezar Life Sciences

Kezar Life Sciences is a clinical-stage biotechnology company founded in 2015 in the United States, focusing on the development of novel, first-in-class, small-molecule therapies for immune-mediated and oncologic disorders. The company's slogan "Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders" reflects their commitment to leveraging cutting-edge science and innovation to transform patient outcomes. Their approach involves harnessing master regulators of cellular function and inhibiting multiple drivers of disease via a single target, with the potential to create significant clinical impact in challenging-to-treat conditions. The company recently received a substantial $12.16M Post-IPO Equity investment on 03 October 2022, with Morningside Venture Investments participating as the lead investor. Kezar's ambitious therapeutic platforms have the potential to address a wide array of indications, offering hope for patients in need across various conditions within the Health Care, Health and Wellness, and Life Sciences sectors.

Taxonomy: Autoimmune Disease, Immunology, Oncology, Drug Discovery, Drug Development, Clinical-stage Biotechnology, Small-molecule Therapies, Immune-mediated Disorders, Oncologic Disorders, Protein Homeostasis, Protein Degradation, Cellular Function, Master Regulators, Intracellular Regulators

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1 •••• •••• 03 Oct 2022
Post-IPO Debt •••••• 1 •••• •••• 10 Nov 2021
Post-IPO Equity •••••• 1
Investor
01 Jan 2020
Series B •••••• 7
Investor Investor Investor Investor Investor
•••• •••• 		25 Jul 2017
Series A •••••• - 05 Jun 2015

Kezar Life Sciences Alternatives & Competitors

Kezar Life Sciences vs
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. United States

A clinical-stage drug platform company focused on treating neuroinflammation.

Private Equity
6 employees
Biotechnology, Pharmaceutical
Compare Kezar Life Sciences vs Jupiter Neurosciences, Inc.
Kezar Life Sciences vs
Annovis Bio, Inc.
Annovis Bio, Inc. United States

Transforming how we treat Alzheimer’s, Parkinson’s, and beyond.

IPO
12 employees
Biotechnology, Health and Wellness
Compare Kezar Life Sciences vs Annovis Bio, Inc.
Kezar Life Sciences vs
Gate Neurosciences
Gate Neurosciences United States

Brain Health, Reimagined

Series Unknown
15 employees
Biotechnology, Health Care
Compare Kezar Life Sciences vs Gate Neurosciences

FAQ About Kezar Life Sciences

Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders
Kezar Life Sciences was founded in 2015.
Kezar Life Sciences is headquartered in South San Francisco, United States.
Kezar Life Sciences operates in the following industries: Health Care, Health and Wellness, Life Sciences.
Kezar Life Sciences has approximately 71 employees.
Kezar Life Sciences has completed 5 funding rounds, raising a total of $135.16M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Kezar Life Sciences include Jupiter Neurosciences, Inc., Annovis Bio, Inc., Gate Neurosciences, Gain Therapeutics, Nordic Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kezar Life Sciences and Jupiter Neurosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kezar Life Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy